Product Information
BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE is a generic product labeled by Actavis Pharma, Inc., priced at $0.3355 per EA under NDC 00591264005. Its NADAC has been published 641 times since Mar 19, 2014.
The High Outlier badge above means this manufacturer's average price in the Butalbital, Acetaminophen, and Caffeine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE
Butalbital, Acetaminophen, and CaffeineStrength
300; 50; 40 mg/1; mg/1; mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00591264005
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ACETAMINOPHEN; BUTALBITAL; CAFFEINEApproval Type
Generic (ANDA)
FDA Application
ANDA040885On Market Since
7/29/2013
Pharmacological Classes
Price Statistics
The NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE has been published 641 times since Mar 19, 2014, and over the history we have for it it has declined 82.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3355 per EA |
|---|---|
| All-time high | $2.6900 (Jul 15, 2015) |
| All-time low | $0.3110 (Apr 22, 2026) |
| 52-week high | $0.4542 |
| 52-week low | $0.3110 |
| Median price | $1.5238 |
| Average price | $1.3954 |
| Largest weekly change | +34.5% (Jun 19, 2024) |
| Weeks tracked | 641 |
| Tracking since | Mar 19, 2014 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE, manufactured by Actavis Pharma, Inc., is $0.3355 per EA (NDC 00591264005), effective Jun 24, 2026.
How has the price of BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE has declined 82.9%. It has been tracked across 641 weekly CMS publications since Mar 19, 2014.
What are the highest and lowest recorded NADAC prices for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE?
Since Mar 19, 2014, the NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE has ranged from a low of $0.3110 (Apr 22, 2026) to a high of $2.6900 (Jul 15, 2015), with a median of $1.5238 per EA.
Are there cheaper alternatives to BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE?
2 NADAC-published products share the same active ingredient, strength, and dosage form as BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE, but none are currently priced below it.
Who manufactures BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE?
BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE (NDC 00591264005) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification